Skip to main content

Table 3 Results from multivariate cox regression of survival parameters

From: Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis

Parameter influencing overall survival HR 95% CI p
Pt. on aspirin (yes vs. no) 0.357 0.149–0.856 *0.021
Not included    
 Vascular invasion (yes vs. no)    0.228
 Serum CA19-9 above median    0.490
 Lymphovascular invasion    0.440
 Adjuvant chemotherapy    0.061
Parameter influencing disease-free survival
 Pt. on aspirin (yes vs. no) 0.316 0.158–0.634 **0.001
 Vascular invasion (yes vs. no) 3.008 1.541–5.871 **0.001
 Not included    
  Tumor diameter (> median vs. ≤ median)    0.081
  Lymphovascular invasion    0.484
Parameter influencing hematogenous-met-free survival    
 Pt. on aspirin (yes vs. no) 0.354 0.162–0.772 *0.009
 Vascular invasion (yes vs. no) 4.330 2.006–9.344 **< 0.001
  Not included    
  Tumor diameter (> median vs. ≤ median)    0.065
  Lymphovascular invasion    0.258